Vertaling van "countries to have access to medicines " (Nederlands → Frans) :

However, it is also important for the population of these countries to have access to medicines of the same quality as those on the European market.
However, it is also important for the population of these countries to have access to medicines of the same quality as those on the European market.

To promote the proper use of a medicine, all relevant parties need to have objective, appropriate, up-todate and readily accessible information.
To promote the proper use of a medicine, all relevant parties need to have objective, appropriate, up-todate and readily accessible information.

The FAMHP and the BUM department in particular ensures that all parties have access to such information, so that medicines can be used rationally and safely.
The FAMHP and the BUM department in particular ensures that all parties have access to such information, so that medicines can be used rationally and safely.

Galvus/Eucreas (USD 115 million, +416% lc), oral treatments for type 2 diabetes, have been expanding rapidly in many European, Latin American and Asia-Pacific markets, and outperforming a competitor medicine in the DPP-IV segment in some countries.
Galvus/Eucreas (USD 115 millions, +416% en m. l.), traitements par voie orale du diabète de type 2, ont progressé rapidement dans de nombreux marches en Europe, en Amérique latine et en Asie-Pacifique.

Galvus and Eucreas, a single-pill combination of Galvus with metformin that accounts for the majority of sales, have outperformed a competitor medicine in the DPP-4 segment in some countries. Galvus was approved in Japan in January 2010 with the brand name Equa.
Galvus et Eucreas, un comprimé unique associant Galvus avec la metformine qui enregistre la majorité des ventes, ont surperformé dans certains pays un médicament concurrent dans le segment DPP-IV. Galvus a été homologué en janvier 2010 au Japon sous la marque Equa.